WOMEN LEADERS IN ONCOLOGY
Dead / Cancelled — Cancelled — Section 8 (as of 17 Jan 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87652646
- Registration number
- 5506735
- Mark type
- Design + words
- Filed
- 19 Oct 2017
- Published for opposition
- 17 Apr 2018
- Registered
- 03 Jul 2018
- Attorney of record
- Matthew J. Gryzlo
Goods and services
- Class 035 — Advertising and business services: Business and professional networking services, namely, creating research, business, and philanthropy connections in the field of oncology drug development, clinical research, and clinical practice; organization and implementation of professional networking opportunities in the nature of arranging and conducting professional business conferences and exhibitions and networking events in the fields of oncology drug development, clinical research, and clinical practice for business networking purposes; Business collaboration services, namely, promoting collaboration between current and rising women leaders in the field of oncology to achieve advances in the field of cancer research and treatment
Owner
- Vaniam Group LLC, Chicago, IL, US
- Vaniam Group LLC, Chicago, IL, US
- Vaniam Group LLC, Chicago, IL, US
Prosecution history
- 17 Jan 2025 — CANCELLED SEC. 8 (6-YR)
- 03 Jul 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Jul 2018 — REGISTERED-PRINCIPAL REGISTER
- 17 Apr 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Apr 2018 — PUBLISHED FOR OPPOSITION
- 28 Mar 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Mar 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Mar 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Mar 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Mar 2018 — ASSIGNED TO LIE
- 26 Feb 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Feb 2018 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 05 Feb 2018 — PRIORITY ACTION E-MAILED
- 05 Feb 2018 — PRIORITY ACTION WRITTEN
- 29 Jan 2018 — ASSIGNED TO EXAMINER